Skip to content. Skip to navigation

Sections

Personal tools

Log in
Join

You are here: Home → Events → The role of materials characterisation in pharmaceutical quality by edisgn & manufacture

Log in: Login Name

Password

Cookies are not enabled. You must enable cookies before you can log in.

Remember Me; Forgot your password?; New user?

Document Actions

The role of materials characterisation in pharmaceutical quality by edisgn & manufacture

Type	Symposium
Language	English
Date	March 22, 2007 from 09:30 am to 05:00 pm
Venue	University of London 29/39 Brusnwick Square London, WC1N 1AX GB
Chemistry Specialties	medicinal and pharmaceutical chemistry
Chemistry Techniques	other
Contact	Julie Chruchill RPSGB 1 Lambeth High Street London, SE1 7JN GB 020 7572 2261 020 7572 2506 science@rpsgb.org
Add event to calendar	vCal (Windows, Linux) iCal (Mac OS X)

by Lisa Gilbert — last modified 12-25-06 01:37 PM

From measurements of individual crystals at the microscopic scale, through to the macroscopic properties of bulk pharmaceutical products, material characterisation techniques play an increasingly central role in product and process understanding. The latest developments in these techniques will be reviewed and also their applications in exploring the pharmaceutical “Design Space” as part of Quality by Design. This meeting may be regarded as the measurement complement of the JPAG symposium held on 7 December 2006 entitled “Material functionality and fitness for purpose in solid dosage forms.”

Speakers

Dr Jim McCabe (AstraZeneca), Dr Neil Feeder (Pfizer Global R&D), Dr Mike Claybourn (AstraZeneca), Prof Clive Roberts (Univ .of Nottingham), Dr Charley Wu (Univ .of Birmingham), Dr Simon Gaisford (ULSoP), Prof Graham Buckton (ULSoP), Dr Andrew Day (AstraZeneca), Dr Keith Pugh (MHRA)